Keytruda to be ‘top drug’ by 2023

7th October 2019 Uncategorised 0

The current best selling drug is AbbVie and Eisai’s anti-inflammatory therapy, Himura.

More: Keytruda to be ‘top drug’ by 2023
Source: News